Drugs for Paget Disease of Bone 3 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 17)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Zoledronic acid |
Approved |
Phase 4 |
|
118072-93-8 |
68740 |
Synonyms:
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonate
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonate
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
ácido zoledrónico
ACLASTA
Aclasta®|CGP-42446|CGP-42446A|Reclast®|zoledronate|Zometa®
ANHYDROUS ZOLEDRONIC ACID
CGP-42446
CGP-42446A
Novartis brand OF zoledronic acid
|
Reclast
ZERLINDA
ZOL
ZOL446
ZOLEDRONATE
Zoledronic acid
Zoledronic acid anhydrous
ZOLEDRONIC ACID HYDRATE
ZOLEDRONIC ACID MONOHYDRATE
ZOLEDRONIC ACID, ANHYDROUS
Zometa
Zometa Concentrate
|
|
2 |
|
Alendronic acid |
Approved |
Phase 4 |
|
121268-17-5, 66376-36-1 |
2088 |
Synonyms:
(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)
(4-Amino-1-hydroxybutylidene)bisphosphonate
(4-Amino-1-hydroxybutylidene)bisphosphonic acid
4 amino 1 Hydroxybutylidene 1,1 biphosphonate
4-amino-1-hydroxybutane-1,1-diphosphonic acid
4-Amino-1-hydroxybutylidene 1,1-biphosphonate
ABDP
ABDP|BPH 1|Fosamax®|MK-217
Acide alendronique
Acide Alendronique [INN-French]
Acido alendronico
Acido Alendronico [INN-Spanish]
Acidum alendronicum
Acidum Alendronicum [INN-Latin]
Adronat
Alendronate
|
Alendronate monosodium salt, trihydrate
Alendronate sodium
Alendronate sodium hydrate
Alendronic acid
Alendros
Aminohydroxybutane bisphosphonate
Arendal
BINOSTO
Bisphosphonate, aminohydroxybutane
BPH 1
Fosamax
Fosamax Plus D
G-704650
MK-217
Onclast
Sodium, alendronate
|
|
3 |
|
Pamidronic acid |
Approved |
Phase 4 |
|
40391-99-9 |
4674 |
Synonyms:
(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate
(3-Amino-1-hydroxypropylidene)-1,1-bisphosphonate
1 Hydroxy 3 aminopropane 1,1 diphosphonic acid
1-Hydroxy-3-aminopropane-1,1-diphosphonic acid
ACIDE PAMIDRONIQUE
Acide pamidronique [INN-French]
ACIDO PAMIDRONICO
Acido pamidronico [INN-Spanish]
ACIDUM PAMIDRONICUM
Acidum pamidronicum [INN-Latin]
AHPrBP
Amidronate
Amino 1 hydroxypropane 1,1 diphosphonate
Amino-1-hydroxypropane-1,1-diphosphonate
Aminohydroxypropylidene diphosphonate
|
Aminomux
Aminopropanehydroxydiphosphonate
APD
ARD233
Aredia
Aredia®|CGP-23339AE|disodium pamidronate
CGP-23339AE
Novartis brand OF pamidronate disodium salt
PAMIDRONATE
Pamidronate calcium
Pamidronate disodium
Pamidronate monosodium
Pamidronic acid
Ribodroat
|
|
4 |
|
Cholecalciferol |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
67-97-0, 1406-16-2 |
5280795 10883523 |
Synonyms:
(+)-Vitamin D3
(1S,3Z)-3-[(2E)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-1-CYCLOHEXANOL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENECYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-{2-[(1R,4E,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL
(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3BETA,Z,7E)-9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL
(3Β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL
(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
3-BETA,Z,7E-9,10-SECOCHOLESTR-5,7,10(19)-TRIEN-3-OL
7-DEHYDROCHOLESTEROL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3BETA-OL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-BETA-OL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL
9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL
ACCRETE D3
ACIFEROL D3
ACTIVATED
Activated 7-dehydrocholesterol
ADCAL-D3
ARACHITOL
AVITICOL
BIOLIFE VITAMIN D3
BIO-VITAMIN D3
CACIT D3
CALCEOS
CALCICHEW D3
CALCICHEW D3 FTE
CALCICHEW D3 ONCE DAILY
CALCI-D
Calciferol
Calciol
CALDRINK D3
CALFOVIT D3
CC
Cholecalciferol
CHOLECALCIFEROL D3
Cholecalciferols
Cholecalciferolum
COLECAL D3
Colecalciferol
Colecalciferolum
COLEKAL-D3
COLEVIT D3
CUBICOLE D3
D3 LEMON MELTS
D3-50
D3-VIGANTOL
DEKRISTOL
DELSTEROL
Delta-D
DEPARAL
DESUNIN
DEVARON
Dihydrocholesterol
DLUX 400
D-MAX
D-TRACETTEN
|
D-VIT3
EBIVIT
E-D3
EVACAL D3
FERACOL
FULTIUM DAILY D3
FULTIUM-D3
GRANUVIT D3
HUX D3
INVITA D3
ISO D3
KORA LIQUID
MICRO-DEE
NATECAL D3
NATURE'S REMEDY VITAMIN D3
NEO-D
NPHD3
NSC-375571
Oleovitamin D3
OSTEOCAPS D3
PLENACHOL
PRO D3
PRO D3 FOLIC
PRO D3 FORTE
PROVITINA
QUINTOX
RICKETON
ROYALVIT D3
STEXEROL-D3
STIVIT-D3
SUNVIT-D3 1,000
SUNVIT-D3 10,000
SUNVIT-D3 2,000
SUNVIT-D3 20,000
SUNVIT-D3 3,000
SUNVIT-D3 400
SUNVIT-D3 5,000
SUNVIT-D3 50,000
SUNVIT-D3 800
SYNERVIT-D3
THEICAL D-3
THORENS
TRIVITAN
VIDDE-3-HYDROSOL
VI-DE3
VIDEKHOL
VIGANTOL
VIGANTOLETTEN
VIGANTOLETTEN 500
VIGORSAN
VIT D3 STREULI
VITA-D3
VITAMIN D
Vitamin D 3
VITAMIN D ASSAY SYSTEM SUITABILITY
Vitamin D NOS
Vitamin D, unspecified form
Vitamin D3
Vitamin D-3
VITINC DAN-DEE-3
ZYMAD
δ-D
|
|
5 |
|
Calcium, Dietary |
|
Phase 4 |
|
|
|
6 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
7 |
|
Vitamins |
|
Phase 4 |
|
|
|
8 |
|
Trace Elements |
|
Phase 4 |
|
|
|
9 |
|
Calciferol |
|
Phase 4 |
|
|
|
10 |
|
Hormones |
|
Phase 4 |
|
|
|
11 |
|
Micronutrients |
|
Phase 4 |
|
|
|
12 |
|
Diphosphonates |
|
Phase 4 |
|
|
|
13 |
|
Calcium |
Nutraceutical |
Phase 4 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
14 |
|
Risedronic acid |
Approved, Investigational |
Phase 3 |
|
105462-24-6 |
5245 |
Synonyms:
1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate
2-(3-Pyridinyl)-1-hydroxyethylidenebisphosphonate
2-(3-Pyridinyl)-1-hydroxyethylidene-bisphosphonate
Acid, risedronic
Acide risédroniqe
Acido risedronico
Acidum risedronicum
Actonel
Actonel 150
Actonel®|Atelvia®|NE-58095|risedronate sodium
Atelvia
Benet
Bisphosphate risedronate sodium
Bisphosphonate risedronate sodium
|
M05BA07
NE-58095
Ridron
Risedronate
Risedronate sodium
Risedronate sodium, bisphosphate
Risedronate sodium, bisphosphonate
Risedronic acid
Risedronic acid, monosodium salt
Risedronsäure
Sodium, bisphosphate risedronate
Sodium, bisphosphonate risedronate
Sodium, risedronate
|
|
15 |
|
Etidronic acid |
Approved |
Phase 3 |
|
2809-21-4, 7414-83-7 |
3305 |
Synonyms:
(1-Hydroxyethylene)diphosphonate
(1-Hydroxyethylene)diphosphonic acid
(1-Hydroxyethylene)diphosphonic acid, tetrapotassium salt
(1-Hydroxyethylidene)bis(phosphonate)
(1-Hydroxyethylidene)bis(phosphonic acid)
(1-Hydroxyethylidene)bisphosphonate
(1-Hydroxyethylidene)bisphosphonic acid
(1-Hydroxyethylidene)diphosphonate
(1-Hydroxyethylidene)diphosphonic acid
(1-HYDROXY-ETHYLIDENE)DIPHOSPHONIC ACID
(Hydroxyethylidene)diphosphonate
(Hydroxyethylidene)diphosphonic acid
1 Hydroxyethane 1,1 diphosphonate
1 Hydroxyethylidene 1,1 bisphosphonate
1,1 Hydroxyethylenediphosphonate
1,1,1-Ethanetriol diphosphonate
1,1,1-Ethanetriol diphosphonic acid
1,1-Hydroxyethylenediphosphonate
1-Hydroxy-1,1-diphosphonoethane
1-HYDROXYETHANE 1,1-DIPHOSPHONIC ACID
1-Hydroxyethane-1,1-bisphosphonate
1-Hydroxyethane-1,1-bisphosphonic acid
1-Hydroxyethane-1,1-diphosphonate
1-Hydroxyethane-1,1-diphosphonic acid
1-Hydroxyethanediphosphonate
1-Hydroxyethanediphosphonic acid
1-Hydroxyethylene diphosphonate, disodium
1-Hydroxyethylidene-1,1-bisphosphonate
1-Hydroxyethylidene-1,1-bisphosphonic acid
1-Hydroxyethylidene-1,1-diphosphonate
1-Hydroxyethylidene-1,1-diphosphonic acid
Acetodiphosphonate
Acetodiphosphonic acid
Acide etidronique
ACIDE ÉTIDRONIQUE
Acide etidronique [INN-French]
Acido etidronico
ÁCIDO ETIDRÓNICO
Acido etidronico [INN-Spanish]
Acidum etidronicum
Acidum etidronicum [INN-Latin]
Cintichem Technetium 99m Hedspa
Dequest 2010
Dequest 2015
Dequest Z 010
Dicalcium ehdp
|
Dicalcium etidronate
Didronel
Didronel IV
Diphosphonate, disodium 1-hydroxyethylene
Diphosphonic acid, hydroxyethylidene
Disodium 1 hydroxyethylene diphosphonate
Disodium 1-hydroxyethylene diphosphonate
Disodium etidronate
EHDP
EHDP, dicalcium
Ethane-1-hydroxy-1,1-bisphosphonate
Ethane-1-hydroxy-1,1-bisphosphonic acid
Ethane-1-hydroxy-1,1-diphosphonate
Ethane-1-hydroxy-1,1-diphosphonic acid
Ethanehydroxydiphosphonate
Ethanehydroxyphosphate
Etidronate
Etidronate disodium
Etidronate, dicalcium
Etidronate, disodium
Etidronate, sodium
Etidronate, tetrapotassium salt
ETIDRONIC ACID
Etidronsaeure
ETIDRONSÄURE
Ferrofos 510
HEDP
HEDSPA
Hydroxyethanediphosphonate
Hydroxyethanediphosphonic acid
Hydroxyethylidene diphosphonic acid
M05BA01
MPI Stannous Diphosphonate
NSC-227995
Osteoscan
Oxyethylidenediphosphonate
Oxyethylidenediphosphonic acid
Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt
Salt etidronate, tetrapotassium
Sodium etidronate
Tetrapotassium salt etidronate
Turpinal SL
Xidifon
Xidiphon
Xydiphone
|
|
16 |
|
calcium channel blockers |
|
Phase 3 |
|
|
|
17 |
|
Fluorides |
|
|
|
|
|
Interventional clinical trials:
(show all 14)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A 6 Months, Open-Label Phase IV Study to Confirm the Safety and Efficacy of Single Intravenous Dose of 5 mg Zoledronic Acid for the Patients of Paget's Disease of Bone (PDB) in China |
Completed |
NCT00774020 |
Phase 4 |
Zoledronic acid |
2 |
An Open Label, Reclast®/Aclasta®, Re-treatment of Relapsed Patients With Paget's Disease of Bone Who Participated in the CZOL446K2304 and CZOL446K2305 Core Registration Studies |
Completed |
NCT00740129 |
Phase 4 |
Zoledronic Acid |
3 |
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation |
Completed |
NCT00668200 |
Phase 4 |
Reclast (ZOL446, zoledronic acid) |
4 |
Bisphosphonate Therapy for Osteogenesis Imperfecta |
Completed |
NCT00159419 |
Phase 4 |
Alendronate;Pamidronate |
5 |
A 6-Month, Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Alendronate 280-mg Oral Buffered Solution Once Weekly in Patients With Paget's Disease of Bone |
Completed |
NCT00480662 |
Phase 3 |
alendronate |
6 |
Randomized, Double-blind, Safety and Efficacy Trial With Intravenous Zoledronic Acid for the Treatment of Paget's Disease of Bone Using Risedronate as a Comparator, Including an Extended Observational Period |
Completed |
NCT00051636 |
Phase 3 |
Zoledronic Acid;Risedronate;Placebo to Risedronate;Placebo to Zoledronic Acid |
7 |
Randomized, Double-Blind, Safety and Efficacy Trial With Intravenous Zoledronic Acid for the Treatment of Paget's Disease of Bone Using Risedronate as a Comparator, Including an Extended Observation Period |
Completed |
NCT00103740 |
Phase 3 |
zoledronic acid;placebo to zoledronic acid;Risedronate;Placebo to risedronate;Calcium and vitamin D supplements |
8 |
Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders |
Unknown status |
NCT00403598 |
|
|
9 |
Genetic Study of Families Affected by Paget's Disease of Bone |
Completed |
NCT00747994 |
|
|
10 |
Sodium Risedronate 17.5 mg Tablets Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) - 48-week Surveillance - |
Completed |
NCT02106455 |
|
Sodium risedronate |
11 |
Use of 18F-Fluoride Positron Emission Tomography in the Assessment and Evaluation of Therapy in Monostotic Paget's Disease of Bone |
Completed |
NCT00306046 |
|
Bisphosphonate treatment |
12 |
Genetic Analysis to Predict the Development of Paget's Disease |
Recruiting |
NCT05309954 |
|
|
13 |
Characterization of Familial Myopathy and Paget Disease of Bone |
Recruiting |
NCT01353430 |
|
|
14 |
Investigation of Pathophysiology of Angiogenesis and Osteogenesis in Paget's Disease of Bone |
Active, not recruiting |
NCT02802384 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Calcitonin
|
salmon calcitonin
|
|